Osteoporosis in Menopause

Journal of Obstetrics and Gynaecology Canada

Volumn 36, Issue 9, 2014, Pages 839-840

  Khan, Aliya ^a   Fortier, Michel ^a   Reid, Robert ^a   Abramson, Beth L ^a   Blake, Jennifer ^a   Desindes, Sophie ^a   Dodin, Sylvie ^a   Graves, Lisa ^a   Guthrie, Bing ^b   Johnston, Shawna ^a   Rowe, Timothy ^a   Sodhi, Namrita ^a   Wilks, Penny ^c   Wolfman, Wendy ^a  

^a NONE   (Canada)

^b NONE   (Canada)

^c Dundas   (Canada)

Author keywords

Anabolic; Antiresorptive; Bisphosphonates; Bone forming agent; Bone mineral density; Bone turnover markers; Calcitonin; Diagnosis; Dual energy x ray absorptiometry; Fragility fractures; Hormone therapy; Osteoporosis; Prevention; Selective estrogen receptor modulator; Treatment; Vertebral fractures

Indexed keywords

ALENDRONIC ACID; CALCIUM; DENOSUMAB; ESTROGEN; PARATHYROID HORMONE[1-34]; RALOXIFENE; RISEDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

ARTICLE; BONE DENSITY; COMPRESSION FRACTURE; DIET SUPPLEMENTATION; FRAGILITY FRACTURE; HIP FRACTURE; HORMONAL THERAPY; HUMAN; LOW DRUG DOSE; MENOPAUSAL SYNDROME; MENOPAUSE; OSTEOPOROSIS; PHYSICAL ACTIVITY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; RISK ASSESSMENT;

EID: 84920117444     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(15)30489-8     Document Type: Article

References (0)